How should I increase the insulin dose for an inpatient patient on a sliding‑scale regimen who is receiving 2 units of regular insulin and has a glucose of 400 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Stop Using Sliding Scale Alone—Transition to Scheduled Basal-Bolus Insulin

For a patient on sliding scale 2 units with glucose of 400 mg/dL, you need to immediately transition from sliding scale monotherapy to a scheduled basal-bolus insulin regimen, as sliding scale alone is ineffective and increases hyperglycemia risk 3-fold. 1

Immediate Action for This Patient

Give 14-16 units of regular insulin NOW as correction dose for glucose ≥400 mg/dL according to the "usual" or "insulin-resistant" column (depending on patient characteristics), then immediately implement a scheduled regimen 1.

Calculate Total Daily Dose (TDD)

Based on the patient's weight and glucose level:

  • For glucose 201-400 mg/dL: Start with 0.5 units/kg/day 1
  • For elderly (≥70 years) or GFR <60: Use 0.2-0.3 units/kg/day 1
  • For glucose >400 mg/dL: Consider starting at the higher end or using insulin-resistant column 1

Distribute the TDD

  • 50% as basal insulin (glargine, detemir, or NPH) given once or twice daily 1
  • 50% as nutritional/prandial insulin divided into three equal doses before meals (rapid-acting analog or regular insulin) 1

Add Correction Insulin

Use the correction scale from the Endocrine Society guideline 1:

For glucose ≥400 mg/dL:

  • Insulin-sensitive patients: 14 units
  • Usual patients: 16 units
  • Insulin-resistant patients: 18 units

This correction dose is ADDED to the scheduled prandial dose, not used alone 1.

Why Sliding Scale Alone Fails

The evidence is unequivocal: sliding scale insulin as monotherapy results in undesirable hyperglycemia and hypoglycemia 1. The Endocrine Society explicitly recommends against prolonged use of sliding scale therapy as the sole method for glycemic control 1. Studies show sliding scale increases hyperglycemia risk 3-fold compared to scheduled insulin 1.

Clinical Algorithm for Insulin Adjustment

If Patient is Eating:

  1. Start basal insulin at calculated dose
  2. Give rapid-acting insulin before each meal (1/6 of TDD per meal)
  3. Add correction insulin per scale above to each prandial dose
  4. Adjust doses by 10-20% every 2-3 days based on glucose patterns 1, 2

If Patient is NPO:

  1. Give basal insulin alone
  2. Add correction doses with rapid-acting analog every 4 hours OR regular insulin every 6 hours
  3. Use the "insulin-sensitive" column for corrections 1

Titration Rules:

  • Increase by 2 units every 3 days to reach fasting glucose goal without hypoglycemia 2, 3
  • For hypoglycemia: Determine cause; if unclear, reduce dose by 10-20% 2, 3
  • For persistent hyperglycemia: Increase corresponding insulin component by 10-15% 2, 3

Common Pitfalls to Avoid

  1. Don't continue sliding scale alone—this is reactive, not preventive, and leads to glucose swings 4, 5, 6

  2. Don't use the same sliding scale throughout hospitalization without adjustment—insulin needs change with clinical status 4

  3. Don't forget to reduce basal by 4 units or 10% when adding prandial insulin if A1C <8% 2

  4. Don't use premixed insulin in hospital—unacceptably high hypoglycemia rates 7

  5. For elderly or renal impairment: Start with insulin-sensitive column and lower weight-based dosing 1

Special Considerations

If on corticosteroids: Start at insulin-resistant column (higher doses) 1

If previously on >80 units/day at home: Use insulin-resistant column 1

If high hypoglycemia risk (age ≥65, BMI ≤27, CKD stage ≥3, TDD ≥0.6 units/kg): Consider real-time CGM if available and start conservatively 8

The basal-bolus approach achieves glucose <140 mg/dL in 68% of patients versus only 38% with sliding scale alone, with no difference in hypoglycemia rates 4. This patient needs scheduled insulin NOW, not continued reactive sliding scale therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.